Answers are grounded in this paper and cite their sources.
Micro- and nanoplastics (MNPs) have been detected in human cardiovascular specimens, and emerging observational evidence suggests an association between measured MNP burden and cardiovascular outcomes. This narrative review examines evidence relevant to coronary artery disease (CAD) across three distinct levels: human cardiovascular observations, experimental cardiovascular models, and mechanisms extrapolated from other systems. Proposed pathways include endothelial oxidative injury, macrophage-mediated chronic inflammation, lipid metabolic disturbance, prothrombotic effects, and dysregulated signaling pathways. We further summarize the limitations prevailing in this research field, such as the absence of unified standards for exposure quantification and particle detection, the predominance of cross-sectional clinical evidence, and unresolved questions regarding the in vivo distribution and metabolic patterns of MNPs. Future research directions are proposed covering standardized detection, in-depth exploration of molecular mechanisms, prospective cohort studies, interdisciplinary translational research, and public health prevention and control. These findings provide theoretical implications for refining CAD prevention and treatment frameworks, when considering MNPs as candidate modifiable environmental risk factors.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: